Skip to Main Content

Paper Details

HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance.
Front Oncol
6
2020
Author NameAffiliation
Pedram HeidariMassachusetts General Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2